Evaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD.

dc.contributor.authorMiravitlles, Marc
dc.contributor.authorSliwinski, Pawel
dc.contributor.authorRhee, Chin Kook
dc.contributor.authorCostello, Richard W
dc.contributor.authorCarter, Victoria
dc.contributor.authorTan, Jessica
dc.contributor.authorLapperre, Therese Sophie
dc.contributor.authorAlcazar, Bernardino
dc.contributor.authorGouder, Caroline
dc.contributor.authorEsquinas, Cristina
dc.contributor.authorGarcía-Rivero, Juan Luis
dc.contributor.authorKemppinen, Anu
dc.contributor.authorTee, Augustine
dc.contributor.authorRoman-Rodríguez, Miguel
dc.contributor.authorSoler-Cataluña, Juan José
dc.contributor.authorPrice, David B
dc.date.accessioned2025-01-07T12:40:21Z
dc.date.available2025-01-07T12:40:21Z
dc.date.issued2018-01-31
dc.description.abstractThe concept of clinical control in COPD has been developed to help in treatment decisions, but it requires validation in prospective studies. This international, multicenter, prospective study aimed to validate the concept of control in COPD [control = stability (no exacerbations or impairment in CAT scores) + low impact (low level of symptoms)]. Data from the screening visit was used to: investigate the level of control, compare characteristics of patients according to the control status, and perform a sensitivity analysis of the levels of control using either clinical criteria or questionnaires (COPD Assessment Test -CAT- or Clinical COPD Questionnaire -CCQ-). A total of 314 patients were analysed, mean age was 68.5 years and mean FEV1 was 52.6% of predicted. According to the prespecified criteria 21% of patients were classified as controlled, all of them with mild/moderate COPD (Body mass index, Obstruction, Dyspnea and Exacerbations, -BODEx-index The proposed criteria of control were only fulfilled by 21% of patients. The suggested cut offs and their predictive value for poor outcomes need to be refined in prospective studies.
dc.identifier.doi10.1016/j.rmed.2018.01.019
dc.identifier.essn1532-3064
dc.identifier.pmid29501251
dc.identifier.unpaywallURLhttp://www.resmedjournal.com/article/S0954611118300283/pdf
dc.identifier.urihttps://hdl.handle.net/10668/24830
dc.journal.titleRespiratory medicine
dc.journal.titleabbreviationRespir Med
dc.language.isoen
dc.organizationSAS - Hospital de Poniente
dc.page.number8-14
dc.pubmedtypeJournal Article
dc.pubmedtypeMulticenter Study
dc.pubmedtypeObservational Study
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.rights.accessRightsopen access
dc.subjectCAT
dc.subjectCCQ
dc.subjectCOPD
dc.subjectControl
dc.subjectOutcomes
dc.subject.meshAged
dc.subject.meshBronchodilator Agents
dc.subject.meshEarly Diagnosis
dc.subject.meshFemale
dc.subject.meshForced Expiratory Volume
dc.subject.meshHumans
dc.subject.meshMale
dc.subject.meshPrognosis
dc.subject.meshProspective Studies
dc.subject.meshPulmonary Disease, Chronic Obstructive
dc.subject.meshSurveys and Questionnaires
dc.subject.meshVital Capacity
dc.titleEvaluation of criteria for clinical control in a prospective, international, multicenter study of patients with COPD.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number136

Files